Real urgency is needed now

SMA testing has been incorporated in newborn screening programmes in many countries due to overwhelming evidence that babies who are treated early have the best response to treatments and in many cases can have normal development.

- DR SITHARA RAMDAS CONSULTANT PAEDIATRIC NEUROLOGIST & SENIOR LECTURER AT OXFORD UNIVERSITY

Delay in inclusion of SMA to the UK newborn screening programme means we continue to see babies diagnosed once they have developed symptoms.